These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2671879)

  • 1. Histopathologic parameters and DNA analysis in colorectal adenocarcinomas.
    Crissman JD; Zarbo RJ; Ma CK; Visscher DW
    Pathol Annu; 1989; 24 Pt 2():103-47. PubMed ID: 2671879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
    Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
    Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
    Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
    Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
    Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic parameters and DNA ploidy as predictors of survival in stage B adenocarcinoma of colon and rectum.
    Robey-Cafferty SS; el-Naggar AK; Grignon DJ; Cleary KR; Ro JY
    Mod Pathol; 1990 May; 3(3):261-6. PubMed ID: 2362936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer.
    Lanza G; Maestri I; Ballotta MR; Dubini A; Cavazzini L
    Mod Pathol; 1994 Feb; 7(2):161-5. PubMed ID: 8008736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic value of DNA ploidy of colorectal tumor cells].
    Givel JC; de Quay N; Albe X; Vassilakos P
    Helv Chir Acta; 1989 Jan; 55(5):679-83. PubMed ID: 2715031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum.
    Taniyama K; Suzuki H; Matsumoto M; Hakamada K; Toyama K; Tahara E
    Jpn J Clin Oncol; 1991 Dec; 21(6):406-11. PubMed ID: 1805045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic significance of flow cytometric DNA analysis in colorectal cancer].
    Ando Y
    Nihon Geka Gakkai Zasshi; 1990 Nov; 91(11):1700-9. PubMed ID: 2277618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma.
    Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
    D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
    Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
    Lanza G; Maestri I; Dubini A; Gafà R
    Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.
    Hedley DW; Friedlander ML; Taylor IW
    Cytometry; 1985 Jul; 6(4):327-33. PubMed ID: 4017799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric DNA and clinicopathologic analysis of Dukes' A&B colonic adenocarcinomas: a retrospective study.
    Visscher DW; Zarbo RJ; Ma CK; Sakr WA; Crissman JD
    Mod Pathol; 1990 Nov; 3(6):709-12. PubMed ID: 2263595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flow cytometric DNA analysis of malignant potential in colorectal cancer].
    Ando Y; Tsuchiya A; Oki S; Sato H; Yoshida T; Kimijima I; Abe R
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():112-7. PubMed ID: 8678552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.